clinical lung cancer

Pulmonary and Respiratory Medicine

Clinical Lung Cancer

Editor in Chief: David Gandara, MD

Clinical Lung Cancer is a peer-reviewed bi-monthly journal established in 1999. It features an international editorial board comprised of prominent thought leaders, including Editor-in-Chief Dr. David Gandara. It is mailed free of charge to US-based medical oncologists, hematologists, radiation oncologists and surgical oncologists. Each issue features peer-reviewed original contributions, invited comprehensive reviews and current treatment reports, commentaries, clinical trial lists, as well as meeting highlights taken from major oncology meetings throughout the year. Also included are brief editorials of current news and the latest topics concerning lung cancer issues relevant to clinicians.

Global Print Circulation
9,501
Avg. Global Monthly Visits
6,341
Avg. Global Monthly Unique Visitors
4,751
Avg. Global Monthly Page Views
10,640
Avg. Global eTOC Distribution
13,649
Circulation updated on February 23, 2023, based on December 2022 BPA Brand Report., eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023,

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Have a question or need assistance?